Thus, besides the classic target XO that plays a critical role in uric acid production, transporters, such as organic anion transporter 1 (OAT1, SLC22A6) and urate transporter 1 (URAT1, SLC22A12) in kidney, might be promising targets for treating hyperuricemia. The gene discussed is SLC22A6; the disease is hyperuricemia.